Class Action Lawsuit Filed Against Immutep Limited (NASDAQ: IMMP) Over Alleged Securities Fraud
A class action lawsuit has been filed against Immutep Limited (IMMP), alleging securities fraud and other unlawful business practices. The firm Pomerantz LLP is representing investors who suffered losses following the announcement of a discontinued clinical trial in March 2026, which led to an 82% drop in IMMP's stock price.
Tickers: $IMMP
Topics: clinical trial discontinuation securities fraud stock price drop